US 12312339
Polo like kinase 4 inhibitors
granted A61KA61K31/416A61K31/4439
Quick answer
US patent 12312339 (Polo like kinase 4 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/416, A61K31/4439, A61K31/497, A61K31/513